| Literature DB >> 29796881 |
Katarzyna Wolny-Koładka1, Anna Lenart-Boroń2.
Abstract
The aim of the study was to determine the antimicrobial resistance profile and the occurrence of extended-spectrum beta-lactamase genes and to analyze the genetic diversity of Escherichia coli strains isolated from the environment of horse riding centers. The study was conducted using E. coli strains isolated from the air, manure, and horse nostril swabs in three horse riding centers differing in the system of horse keeping-stable (OJK Pegaz and KJK Szary) and free-range (SKH Nielepice). Resistance to antibiotics was determined using the disk-diffusion method, and the PCR technique was employed to detect the extended-spectrum β-lactamase (ESBL) genes, while the genetic diversity of strains was assessed by rep-PCR. A total of 200 strains were collected during the 2-year study, with the majority isolated from KJK Szary, while the smallest number was obtained from SKH Nielepice. The strains were mostly resistant to ampicillin, aztreonam, and ticarcillin. The tested strains were most frequently resistant to one or two antibiotics, with a maximum of ten antimicrobials at the same time. Two multidrug-resistant (MDR) strains were detected in OJK Pegaz while in KJK Szary there were two MDR and one extensively drug-resistant (XDR) strain. The ESBL mechanism was most frequently observed in OJK Pegaz (20.31% of strains) followed by KJK Szary (15.53% of strains) and SKH Nielepice (15.15% of strains). Among the ESBL-determining genes, only blaTEM and blaCTXM-9 were detected-blaTEM was mostly found in KJK Szary (53.40% of strains), while the second detected gene-blaCTXM-9-was most frequent in SKH Nielepice (6.06% of strains). The rep-PCR genotyping showed high variation among the analyzed strains, whereas its degree differed between the studied facilities, indicating that the type of horse keeping (stable vs. free-range) affects the genetic diversity of the E. coli strains. Having regard to the fact that the tested strains of E. coli were derived from non-hospitalized horses that were not treated pharmacologically, we can assume that the observed antimicrobial resistance may be of both-natural origin, i.e., not the result of the selection pressure, and acquired, the source of which could be people present in the horse riding facilities, the remaining horses which were not included in the study, and air, as well as water, fodder, and litter of the animals. Therefore, it can be concluded that the studied horses are the source of resistant E. coli and it is reasonable to continue monitoring the changes in antimicrobial resistance in those bacteria.Entities:
Keywords: Antibiotics; Antimicrobial resistance; Escherichia coli; Extended-spectrum beta-lactamases, horses
Mesh:
Substances:
Year: 2018 PMID: 29796881 PMCID: PMC6063325 DOI: 10.1007/s11356-018-2274-x
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 4.223
Description of primers used in the study
| Gene | 5′–3′ sequence | Annealing temperature (°C) | Product length (bp) | Reference |
|---|---|---|---|---|
|
| F: GTTACAATGTGTGAGAAGCAG | 60 | 800 | Costa et al. |
|
| F: GTGACAAAGAGAGTGCAACGG | 54 | 860 | Simarro et al. |
|
| F: ACACAATACATATCAACTTCGC | 61 | 813 | Sáenz et al. |
|
| F: CACTCAAGGATGTATTGTG | 52 | 885 | Sáenz et al. |
|
| F: ATTCTTGAAGACGAAAGGGC | 60 | 1150 | Sáenz et al. |
Frequency (%) of antimicrobial resistance in E. coli strains isolated from three horse riding centers
| Antimicrobial, symbol (μg) | Breakpoint values (mm) | Strain origin | Mean | OJK Pegaz | Mean | KJK Szary | Mean | SKH Nielepice | Mean | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OJK | KJK | SKH | M | A | S | M | A | S | M | A | S | ||||||
| Number of isolates |
|
|
|
|
| 7 |
|
|
|
|
|
|
| 0 |
|
| |
| Share % of isolates in the total number of strains |
|
|
| – |
|
|
| – |
|
|
| – |
| 0 |
| – | |
| Amikacin (AK, 30) | 18/15 (EUCAST | 3.13 | 0 | 0 | 1.04 | 0 | 0 | 6.45 | 2.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amoxicillin/clavulanic acid (AMC, 30) | 19 (EUCAST | 1.56 | 1.94 | 9.09 | 4.2 | 0 |
| 0 | 4.76 | 0 | 0 | 4.26 | 1.42 | 0 | 0 |
| 7.14 |
| Ampicillin (AMP, 10) | 14 (EUCAST |
| 2.91 |
|
| 7.69 |
|
|
| 2.56 | 5.88 | 2.13 | 3.52 | 5.26 | 0 |
|
|
| Aztreonam (ATM, 30) | 26/21 (EUCAST | 9.38 |
| 6.06 |
|
|
| 3.23 |
| 7.69 |
|
|
| 0 | 0 |
| 4.76 |
| Cefamandole (MA, 30) | 18/14 (Barry et al. | 1.56 | 3.88 | 0 | 1.82 | 0 |
| 0 | 4.76 | 2.56 | 5.88 | 4.26 | 4.23 | 0 | 0 | 0 | 0 |
| Cefepime (FEP, 30) | 27/21 (EUCAST | 1.56 | 1.94 | 0 | 1.17 | 3.85 | 0 | 0 | 1.28 | 0 | 0 | 4.26 | 1.42 | 0 | 0 | 0 | 0 |
| Cefotaxime (CTX, 30) | 20/17 (EUCAST | 0 | 0.97 | 0 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 2.13 | 0.71 | 0 | 0 | 0 | 0 |
| Cefoxitin (FOX, 30) | 19 (EUCAST | 3.13 | 3.88 | 9.09 | 5.37 | 3.85 |
| 0 | 6.04 | 2.56 | 0 | 6.38 | 2.98 | 5.26 | 0 |
| 6.52 |
| Ceftazidime (CAZ, 30) | 22/19 (EUCAST | 4.69 |
| 3.03 | 6.78 | 3.85 |
| 3.23 | 7.12 | 7.69 |
|
|
| 0 | 0 | 7.14 | 2.38 |
| Cefalotin (KF, 30) | 13 (Kronvall et al. | 3.13 | 5.83 |
| 9.04 | 0 | 0 | 6.45 | 2.15 | 2.56 | 0 |
| 4.4 | 5.26 | 0 |
|
|
| Cefazolin (KZ, 30) | 23/19 (Turnidge | 0 | 3.88 | 9.09 | 4.32 | 0 | 0 | 0 | 0 | 0 | 0 | 8.51 | 2.84 | 5.26 | 0 |
| 6.52 |
| Ciprofloxacin (CIP, 5) | 26/24 (EUCAST | 0 | 0.97 | 0 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 2.13 | 0.71 | 0 | 0 | 0 | 0 |
| Gentamicin (CN, 10) | 17/14 (EUCAST | 3.13 | 1.94 | 0 | 1.69 | 0 | 0 | 6.45 | 2.15 | 0 | 5.88 | 2.13 | 2.67 | 0 | 0 | 0 | 0 |
| Netilmicin (NET, 30) | 15/12 (EUCAST | 0 | 1.94 | 3.03 | 1.66 | 0 | 0 | 0 | 0 | 2.56 | 0 | 2.13 | 1.56 | 5.26 | 0 | 0 | 1.75 |
| Piperacillin (PRL, 100) | 20/17 (EUCAST | 3.13 | 3.88 | 0 | 2.34 | 0 |
| 3.23 | 5.84 | 5.13 | 5.88 | 2.13 | 4.38 | 0 | 0 | 0 | 0 |
| Piperacillin/tazobactam (TZP, 110) | 20/17 (EUCAST | 0 | 1.94 | 0 | 0.65 | 0 | 0 | 0 | 0 | 2.56 | 0 | 2.13 | 1.56 | 0 | 0 | 0 | 0 |
| Tetracycline (TE, 30) | 15/11 (Sader et al. |
| 4.85 | 0 | 6.31 |
|
|
|
| 2.56 | 5.88 | 6.38 | 4.94 | 0 | 0 | 0 | 0 |
| Ticarcillin (TIC, 75) | 23 (EUCAST |
| 5.83 |
|
|
|
|
|
| 2.56 | 5.88 | 8.51 | 5.65 | 5.26 | 0 |
|
|
| Tobramycin (TOB, 10) | 17/14 (EUCAST | 3.13 | 1.94 | 3.03 | 2.7 | 0 | 0 | 6.45 | 2.15 | 0 | 0 | 4.26 | 1.42 | 5.26 | 0 | 0 | 1.75 |
| Trimethoprim/sulfamethoxazole (SXT, 25) | 14/11 (EUCAST | 1.56 | 2.91 | 0 | 1.49 | 3.85 | 0 | 0 | 1.28 | 5.13 | 5.88 | 0 | 3.67 | 0 | 0 | 0 | 0 |
| ESBL | – |
|
|
|
|
|
|
|
|
| 5.88 |
|
|
| 0 | 7.14 | 9.4 |
| blaTEM | – |
|
|
|
|
|
|
|
|
|
|
|
|
| 0 |
|
|
| blaCTXM-9 | – | 4.69 | 0.97 | 6.06 | 3.91 | 3.85 |
| 3.23 | 7.12 | 0 | 5.88 | 0 | 1.96 | 5.26 | 0 | 7.14 | 4.13 |
Values > 10 are bolded
M manure, A air, S swab
Number of E. coli isolates with MDR and XDR phenotype and resistant to different numbers of antibiotics
| OJK Pegaz | KJK Szary | SKH Nielepice | Total | Mean | |
|---|---|---|---|---|---|
| MDR | 2 | 2 | 0 | 4 | 1.33 |
| XDR | 0 | 1 | 0 | 1 | 0.33 |
| 10 | 0 | 1 | 0 | 1 | 0.33 |
| 9 | 0 | 0 | 0 | 0 | 0 |
| 8 | 0 | 1 | 0 | 1 | 0.33 |
| 7 | 0 | 0 | 1 | 1 | 0.33 |
| 6 | 0 | 0 | 0 | 0 | 0 |
| 5 | 1 | 2 | 1 | 4 | 1.33 |
| 4 | 4 | 1 | 1 | 6 | 2 |
| 3 | 0 | 4 | 1 | 5 | 1.67 |
| 2 | 9 | 12 | 6 | 27 | 9 |
| 1 | 16 | 15 | 4 | 35 | 11.67 |
| 0 | 34 | 67 | 19 | 120 | 40 |
Fig. 1Results of PCR detection of ESBL-determining genes; a blaTEM, b blaCTXM-9. Lane M, DNA size marker GeneRuler 1 kb DNA Ladder (Thermo Scientific)
Fig. 2UPGMA dendrograms of E. coli strains isolated from various environments (A—air, M—manure, S—swabs) of three horse riding centers. a OJK Pegaz. b KJK Szary. c SKH Nielepice
The results of AMOVA analysis for 183 isolates grouped into three populations (horse riding centers)
| Source of variation | Sum of squares | Variance components | Percentage of variation |
|---|---|---|---|
| Among populations | 15.876 | 0.10230 | 6.41 |
| Within populations | 267.260 | 1.49307 | 93.59 |
| Total | 283.137 | 1.59537 | 100 |
| Fixation index—Fst | 0.06412 |
Characteristics of most frequenta haplotypes within strains isolated from the analyzed horse riding centers
| Haplotype | No. of isolates | Detected in (environment) | Detected in (facility) | ||||
|---|---|---|---|---|---|---|---|
| A ( | M ( | S ( | N ( | P ( | S ( | ||
| Ec_1 | 27 | 3 | 15 | 9 | 5 | 9 | 13 |
| Ec_2 | 17 | 6 | 4 | 7 | 1 | 2 | 14 |
| Ec_3 | 14 | 1 | 6 | 7 | 0 | 11 | 3 |
| Ec_4 | 10 | 2 | 4 | 4 | 3 | 5 | 2 |
| Ec_5 | 8 | 0 | 5 | 3 | 3 | 4 | 1 |
| Ec_6 | 8 | 0 | 5 | 3 | 2 | 4 | 2 |
| Ec_7 | 7 | 0 | 6 | 1 | 6 | 0 | 1 |
| Ec_8 | 7 | 0 | 3 | 4 | 0 | 7 | 0 |
| Ec_9 | 6 | 0 | 2 | 4 | 0 | 4 | 2 |
| Ec_10 | 5 | 0 | 2 | 3 | 1 | 0 | 4 |
| Ec_11 | 4 | 3 | 0 | 1 | 1 | 3 | 0 |
| Ec_12 | 4 | 0 | 0 | 4 | 2 | 2 | 0 |
| Ec_13 | 3 | 1 | 1 | 1 | 0 | 0 | 3 |
| Ec_14 | 3 | 0 | 2 | 1 | 1 | 0 | 2 |
| Ec_15 | 3 | 0 | 2 | 1 | 0 | 0 | 3 |
| Ec_16 | 3 | 2 | 0 | 1 | 1 | 2 | 0 |
aOnly haplotypes specific for three or more isolates are presented